Pfizer Inc. (PFE)
NYSE · Healthcare
Pfizer Inc. Long Term Debt 2007–2025
Pfizer Inc. annual long term debt history from 2008 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Pfizer Inc. long term debt as of December 31, 2025: 61.64B, a 7.38% increase year-over-year.
- Pfizer Inc. long term debt for 2025 were 61.64B, a 7.38% increase from 2024.
- Pfizer Inc. long term debt for 2024 were 57.41B, a 6.72% decrease from 2023.
- Pfizer Inc. long term debt for 2023 were 61.54B, a 87.14% increase from 2022.
- Pfizer Inc. long term debt for 2022 were 32.88B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pfizer Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $61,641 |
| 2024 | $57,405 |
| 2023 | $61,538 |
| 2022 | $32,884 |
| 2021 | $36,195 |
| 2020 | $4,000 |
| 2019 | $35,955 |
| 2018 | $32,909 |
| 2017 | $33,538 |
| 2016 | $31,398 |
| 2013 | $30,462 |
| 2012 | $31,036 |
| 2011 | $34,926 |
| 2010 | $38,410 |
| 2009 | $43,193 |
Pfizer Inc. Long Term Debt — FAQ
Pfizer Inc. (PFE) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PFE's long term debt history?
The chart and table above show Pfizer Inc.'s long term debt by year and by quarter, including the growth rate.